NASDAQ · CBLLHealthcareElectromedical Equipment

CeriBell financials

$24.86+1.43%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
Revenue$89.1M$65.4M
Gross profit$78.3M$56.8M
Gross margin87.9%86.7%
Operating income-$58.4M-$39.7M
Net income-$53.4M-$40.5M
Net margin−60.0%−61.8%
Diluted EPS$-1.46$-3.39
EBITDA-$57.1M-$38.6M
Operating cash flow-$40.8M-$35.0M
Free cash flow-$42.3M-$36.6M
Diluted shares36.5M11.9M

Balance sheet

Period endDec 31Dec 31
Cash & equivalents$40.5M$194.4M
Short-term investments$118.8M$0.00
Total debt$19.8M$19.6M
Total assets$195.8M$225.4M
Total liabilities$40.5M$34.2M
Shareholders' equity$155.3M$191.2M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology